Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2020-11-05 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
109年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 109年09月30日 (which corresponds to the third quarter of 2020). The presence of detailed financial statement data (assets, liabilities, equity) indicates this is a financial report rather than a brief announcement or certification. The document length is 3677 characters, which is relatively short but contains substantive financial data. The content corresponds to a quarterly financial report (interim report) rather than a full annual report or earnings release summary. There is no indication that this is an announcement of a report or a certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2020
2020-11-05 Chinese
109年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data in a consolidated equity changes table for the first three quarters of the fiscal year 109 (which corresponds to 2020 in the Taiwanese calendar) and the same period in the previous year. It includes accounting items such as common stock capital, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign exchange differences, treasury stock, and total equity attributable to the parent company and non-controlling interests. The data is presented in a structured tabular format with monetary units in thousands of New Taiwan Dollars. The document is 3947 characters long, which is relatively short but contains substantive financial data rather than just an announcement or a certification. The content corresponds to an interim or quarterly financial report, as it covers a period shorter than a full fiscal year (the first three quarters). Therefore, the document should be classified as an Interim / Quarterly Report (IR). 9M 2020
2020-11-05 Chinese
109年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by company insiders, including directors, managers, and their related parties. It includes data on shares held at appointment, monthly increases and decreases, and current holdings. The content focuses on insider share transactions and holdings disclosures. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is not a report or announcement of a report but a direct disclosure of insider share transactions. Therefore, the document fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data, not just a notice or announcement.
2020-10-14 Chinese
109年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by company insiders, including directors, managers, and related parties, showing their current holdings, pledged shares, and related percentages. It is a disclosure of insider shareholdings and pledges rather than a financial report, meeting announcement, or voting result. There is no indication of financial statements, earnings data, or meeting materials. This type of document corresponds to a Director's Dealing report, which tracks personal share transactions or holdings by company directors and executives.
2020-10-14 Chinese
109年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, nor does it announce or attach a full report. The content is regulatory in nature, providing compliance information about financial guarantees and loans, typical of a regulatory filing. The document length is short (601 characters), and it does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS).
2020-10-08 Chinese
109年9月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍 for the period 民國109年09月 (September 2020). It includes comparative figures from the previous year and percentage changes. The document is very short (766 characters) and contains no detailed financial statements, management discussion, or comprehensive analysis. It appears to be a regulatory disclosure of revenue figures rather than a full financial report or earnings release. There is no indication of an earnings announcement or conference call transcript. The document is more of a regulatory filing or a brief financial summary. Given the short length and nature, it fits best under Regulatory Filings (RNS) as a general regulatory announcement of financial data without detailed reporting or analysis.
2020-10-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.